Navigation Links
Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder
Date:11/6/2008

WALTHAM, Mass., Nov. 6 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that the Company has initiated a Phase 2b clinical trial to evaluate the use of RG2417, an oral formulation of uridine, in patients with bipolar depression. This Phase 2b study is a multi-center, randomized, double-blind, placebo-controlled clinical trial in which approximately 150 patients with bipolar depression will receive either RG2417 or placebo twice daily for eight weeks. This study is designed to assess the safety and efficacy of RG2417 as measured by the Montgomery-Asberg Depression Rating Scale (MADRS) and the Clinical Global Impression of Change in Bipolar Disorder Scale (CGI-BP-C). The study will be conducted at approximately 20 clinical sites within the United States. The Principal Investigator of this study is Gary S. Sachs, M.D., founder and director of the Bipolar Clinic and Research Program at the Massachusetts General Hospital and an Associate Professor of Psychiatry at the Harvard Medical School.

"Episodes of depression are the most frequent and long-lived symptom of bipolar disorder and account for the majority of the disease impairment. Current therapies used to treat bipolar depression are often ineffective and may have significant side effects, resulting in bipolar depression as an area of high unmet medical need," said Walter C. Herlihy, President and Chief Executive Officer of Repligen. "We look forward to confirming our prior results with RG2417 in bipolar depression in this larger proof-of-concept clinical trial."

The trial is designed to confirm and extend the results obtained in a positive Phase 2a clinical trial of RG2417 in which 83 patients with bipolar disorder received either RG2417 or place
'/>"/>

SOURCE Repligen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Repligen Reports Second Quarter Fiscal Year 2008 Financial Results
2. Repligen to Present at Upcoming Healthcare Conferences Wednesday, November 28th and Wednesday, December 5th
3. Repligen Elects Earl Henry, M.D. to the Board of Directors
4. Repligen Announces Conference Call to Update Orencia(R) Lawsuit
5. Repligen Announces Share Repurchase Program
6. Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors
7. Repligen Announces Conference Call of Second Quarter Fiscal Year 2009 Results Thursday, November 6th, 10:00 a.m. EST
8. Tyco International Increases Quarterly Dividend 36 Percent to 15 Cents per Share; Initiates New $1 Billion Share Repurchase Program
9. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
10. Vista Partners Initiates Coverage on Raptor Pharmaceuticals Corp.
11. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... ... The Thule Atmos X4 offers protection with minimal bulk. At the Thule ... rigorous standards. Due to its Bi-ComponentArmor and ShockStop corners, it passed Thule’s 2 meter ... , The Thule Atmos X4 has also been designed with function in mind. ...
(Date:7/1/2015)... ... 2015 , ... Nutritional Products International, a brand focused on the global marketing ... 2015 ECRM Diet, Vitamin & Sports Nutrition conference in Tampa, Florida, where it made ... trade show allows companies the chance to meet with a variety of the most ...
(Date:7/1/2015)... Tampa, Florida (PRWEB) , ... July 01, 2015 ... ... firm in the legal medical cannabis space, created a web-based resource where legal ... accelerators. First Harvest Financial brings together visionary entrepreneurs and medical marijuana advocates looking ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... clinics throughout New York and New Jersey, acquired South Bay Sports & Physical ... of state-of-the-art clinics. At this most recent member of the Professional family, patients ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... eastern, Persian and Mediterranean foods and groceries. Persianbazzar.com has recently announced that their ... BBQ season, http://persianbazzar.com added great product lines such as BBQ skewers, ...
Breaking Medicine News(10 mins):Health News:NPI Meets With Top Retail Figures at ECRM Conference 2Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 2Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 3Health News:Professional Physical Therapy Acquires Copiague’s South Bay Sports & Physical Therapy, P.C. 2Health News:Persian Bazzar Now Announces the Addition of Golden Star Food and Kitchenware to their website. 2Health News:Persian Bazzar Now Announces the Addition of Golden Star Food and Kitchenware to their website. 3
... Comparative trials and observational studies previously conducted in ... These studies were performed before intracoronary stents and ... ,Therefore, Dr. Hanoch Hod, of Chaim Sheba ... followed 130 consecutive patients aged 70 or older ...
... vasectomy, contraception is typically left up to the woman. ... in a woman's contraceptive repertoire. Until now, men have ... searching for new options. Now, they may have one.// ... 12 percent. Vasectomies are considered permanent. Dr. Wang, of ...
... of choice for some doctors who think it's time to ... French physician invented it in the early 1800s. "The stethoscope ... allow you to distinguish between a heart that is beating ... ,"Sometimes the heart muscle is very weakened, but unless that ...
... spreads fast, and when it does, it can kill within months. ... tracks. ,Faith was more than a mere crutch for Rev. Jerry ... afraid of dying. My faith sustained me in that, but I ... highly curable if it's caught early, but it does not respond ...
... be found in water which has flowed through arsenic-rich ... drinking arsenic-rich water over long periods in countries world-wide. ... the earth's crust. ,Arsenic is introduced into water through ... groundwater //in some areas are elevated as a result ...
... affects women of child-bearing age, occurs when the the ... rendering them unable to produce eggs. PCOS symptoms include ... have said women// without these symptoms still can have ... though women's health experts caution that not every woman ...
Cached Medicine News:Health News:Angioplasty plus stenting better than thrombolysis for elderly patients with AMI, 2Health News:Arsenic in drinking water 2Health News:Arsenic in drinking water 3Health News:Arsenic in drinking water 4Health News:Arsenic in drinking water 5Health News:Arsenic in drinking water 6Health News:Arsenic in drinking water 7Health News:Arsenic in drinking water 8Health News:Polycystic Ovarian Syndrome(PCOS) linked to Diabetes 2
(Date:6/30/2015)... Pa. , June 30, 2015 Zynerba Pharmaceuticals, ... on Form S-1 with the U.S. Securities and Exchange Commission ... common stock. The number of shares to be offered and ... determined. Jefferies LLC and Piper Jaffray ... offering, and Canaccord Genuity Inc. and Oppenheimer & Co. Inc. ...
(Date:6/30/2015)... , June 30, 2015 Dipexium Pharmaceuticals, ... pharmaceutical company focused on the development and commercialization ... closing of its previously announced underwritten public offering ... also exercised their over-allotment option in full to ... The net proceeds to Dipexium are ...
(Date:6/30/2015)... VALLEY, Pa. , June 30, 2015 /PRNewswire/ ... and delivering innovative solutions for medical and surgical ... is guaranteeing next-day replacements for surgical equipment at ... product manufacturer to offer this type of guarantee. ... Olympus Full Service Agreement earlier this year. ...
Breaking Medicine Technology:Zynerba Files Registration Statement for Proposed Initial Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: